FDA — authorised 2 January 1973
- Application: NDA016954
- Marketing authorisation holder: JANSSEN PHARMS
- Local brand name: MICRONOR
- Indication: TABLET — ORAL-28
- Status: approved
🇺🇸 Progestin Only Contraceptive Pills in United States
FDA authorised Progestin Only Contraceptive Pills on 2 January 1973
Marketing authorisations
FDA — authorised 21 October 2002
- Application: ANDA076177
- Marketing authorisation holder: DR REDDYS LABS SA
- Local brand name: CAMILA
- Indication: TABLET — ORAL-28
- Status: approved
FDA — authorised 21 October 2002
- Application: ANDA076225
- Marketing authorisation holder: DR REDDYS LABS SA
- Local brand name: ERRIN
- Indication: TABLET — ORAL-28
- Status: approved
FDA — authorised 23 May 2019
- Application: NDA211367
- Marketing authorisation holder: EXELTIS USA INC
- Local brand name: SLYND
- Indication: TABLET — ORAL
- Status: approved
FDA
- Status: approved
Progestin Only Contraceptive Pills in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Progestin Only Contraceptive Pills approved in United States?
Yes. FDA authorised it on 2 January 1973; FDA authorised it on 21 October 2002; FDA authorised it on 21 October 2002.
Who is the marketing authorisation holder for Progestin Only Contraceptive Pills in United States?
JANSSEN PHARMS holds the US marketing authorisation.